<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Fuad El-Hibri Network &#187; Chairman of the Board</title>
	<atom:link href="http://fuad-elhibri.net/category/chairman-of-the-board/feed/" rel="self" type="application/rss+xml" />
	<link>http://fuad-elhibri.net</link>
	<description>Network of Fuad El-Hibri</description>
	<lastBuildDate>Mon, 30 Aug 2010 06:38:52 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript</title>
		<link>http://fuad-elhibri.net/2009/08/13/emergent-biosolutions-inc-q2-2009-earnings-call-transcript/</link>
		<comments>http://fuad-elhibri.net/2009/08/13/emergent-biosolutions-inc-q2-2009-earnings-call-transcript/#comments</comments>
		<pubDate>Thu, 13 Aug 2009 17:30:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Chairman of the Board]]></category>
		<category><![CDATA[Chairman of the Board of Directors]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Emergent]]></category>
		<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Executive Profile]]></category>
		<category><![CDATA[Fuad El-Hibri]]></category>
		<category><![CDATA[Fuad Elhibri]]></category>
		<category><![CDATA[Investor relations]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[Chief financial officer]]></category>
		<category><![CDATA[Chief operating officer]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Vice president]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.net/?p=82</guid>
		<description><![CDATA[Emergent BioSolutions Inc., (EBS)
Q2 2009 Earnings Call
August 6, 2009 5:00 pm ET
 
Executives
Robert G. Burrows &#8211; Vice President, Investor Relations
Fuad El-Hibri &#8211; Chairman of the Board, Chief Executive Officer
R. Don Elsey &#8211; Chief Financial Officer
Daniel J. Abdun-Nabi &#8211; President, Chief Operating Officer
W. James Jackson, Ph.D. &#8211; Senior Vice President and Chief Scientific Officer
 
Analysts
Eric Schmidt [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;">Emergent BioSolutions Inc., (<a title="More opinion and analysis of EBS" href="http://seekingalpha.com/symbol/ebs">EBS</a>)</p>
<p style="text-align: justify;">Q2 2009 Earnings Call</p>
<p style="text-align: justify;">August 6, 2009 5:00 pm ET</p>
<p style="text-align: justify;"><strong> </strong></p>
<p style="text-align: justify;"><strong>Executives</strong></p>
<p style="text-align: justify;">Robert G. Burrows &#8211; Vice President, <a class="zem_slink" title="Investor relations" rel="wikipedia" href="http://en.wikipedia.org/wiki/Investor_relations">Investor Relations</a></p>
<p style="text-align: justify;"><a href="http://seekingalpha.com/article/154549-emergent-biosolutions-inc-q2-2009-earnings-call-transcript">Fuad El-Hibri</a> &#8211; <a class="zem_slink" title="Chairman" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chairman">Chairman of the Board</a>, <a class="zem_slink" title="Chief executive officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_executive_officer">Chief Executive Officer</a></p>
<p style="text-align: justify;">R. Don Elsey &#8211; <a class="zem_slink" title="Chief financial officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_financial_officer">Chief Financial Officer</a></p>
<p style="text-align: justify;">Daniel J. Abdun-Nabi &#8211; President, <a class="zem_slink" title="Chief operating officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_operating_officer">Chief Operating Officer</a></p>
<p style="text-align: justify;">W. James Jackson, Ph.D. &#8211; <a class="zem_slink" title="Vice president" rel="wikipedia" href="http://en.wikipedia.org/wiki/Vice_president">Senior Vice President</a> and <a class="zem_slink" title="Chief science officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_science_officer">Chief Scientific Officer</a></p>
<p style="text-align: justify;"><strong> </strong></p>
<p style="text-align: justify;"><strong>Analysts</strong></p>
<p style="text-align: justify;">Eric Schmidt &#8211; Cowen &amp; Company</p>
<p style="text-align: justify;">David Moskowitz &#8211; Caris &amp; Company</p>
<p style="text-align: justify;">Mona Ashiya &#8211; J.P. Morgan</p>
<p style="text-align: justify;">Sean Long – Kennedy Capital Management</p>
<p style="text-align: justify;"><strong> </strong></p>
<p style="text-align: justify;"><strong>Presentation</strong></p>
<p style="text-align: justify;"><strong> </strong></p>
<p style="text-align: justify;"><strong>Operator</strong></p>
<p style="text-align: justify;">Welcome to the Emergent BioSolutions Incorporated second quarter 2009 financial results conference call. (Operator Instructions) I would now like to turn the call over to Mr. Robert Burrows.</p>
<p style="text-align: justify;"><strong>Robert Burrows</strong></p>
<p style="text-align: justify;">Good afternoon ladies and gentlemen. My name is Robert Burrows, Vice President of Investor Relations for Emergent. Thank you for joining us today as we discuss Emergent BioSolutions financial results for the second quarter and first six months of 2009. As is customary, our call today is open to all participants. In addition, the call is being recorded and is copyrighted by Emergent BioSolutions&#8230;.</p>
<div class="zemanta-pixie" style="margin-top: 10px; height: 15px; text-align: justify;"><a class="zemanta-pixie-a" title="Reblog this post [with Zemanta]" href="http://reblog.zemanta.com/zemified/4e6f1090-3aa1-46cb-965a-70dde540160c/"><img class="zemanta-pixie-img" style="border: medium none; float: right;" src="http://img.zemanta.com/reblog_e.png?x-id=4e6f1090-3aa1-46cb-965a-70dde540160c" alt="Reblog this post [with Zemanta]" /></a><span class="zem-script more-related pretty-attribution"><script src="http://static.zemanta.com/readside/loader.js" type="text/javascript"></script></span></div>
]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.net/2009/08/13/emergent-biosolutions-inc-q2-2009-earnings-call-transcript/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mr Fuad El-Hibri, Chief Executive Officer and Chairman, Emergent BioSolutions Inc.</title>
		<link>http://fuad-elhibri.net/2009/07/06/mr-fuad-el-hibri-chief-executive-officer-and-chairman-emergent-biosolutions-inc/</link>
		<comments>http://fuad-elhibri.net/2009/07/06/mr-fuad-el-hibri-chief-executive-officer-and-chairman-emergent-biosolutions-inc/#comments</comments>
		<pubDate>Mon, 06 Jul 2009 00:57:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Chairman of the Board]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Fuad El-Hibri]]></category>
		<category><![CDATA[Board of directors]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Corporation]]></category>
		<category><![CDATA[Stanford University]]></category>
		<category><![CDATA[Subsidiary]]></category>
		<category><![CDATA[University of Oxford]]></category>
		<category><![CDATA[Venture capital]]></category>
		<category><![CDATA[Yale University]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.net/?p=7</guid>
		<description><![CDATA[Mr. Fuad El-Hibri has served as chief executive officer and as chairman of the board of directors of Emergent BioSolutions since June 2004 and as president since March 2006. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of BioPort Corporation from May 1998 until June 2004, when, as a [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><img src="http://www.terrapinn.com/TRes/Customer/C471970.jpg" alt="" hspace="8" vspace="5" width="110" height="154" align="right" /><span class="bioText">Mr. <a href="http://www.terrapinn.com/2007/alliance/SpeakerList.stm">Fuad El-Hibri</a> has served as <a class="zem_slink" title="Chief executive officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_executive_officer">chief executive officer</a> and as chairman of the <a class="zem_slink" title="Board of directors" rel="wikipedia" href="http://en.wikipedia.org/wiki/Board_of_directors">board of directors</a> of Emergent BioSolutions since June 2004 and as president since March 2006. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of <a class="zem_slink" title="NYSE: EBS" rel="stockexchange" href="http://finance.yahoo.com/q?s=EBS">BioPort</a> Corporation from May 1998 until June 2004, when, as a result of a <a class="zem_slink" title="Corporation" rel="wikipedia" href="http://en.wikipedia.org/wiki/Corporation">corporate</a> reorganization, BioPort became a <a class="zem_slink" title="Subsidiary" rel="wikipedia" href="http://en.wikipedia.org/wiki/Subsidiary">wholly owned subsidiary</a> of Emergent. The Company subsequently renamed BioPort as Emergent BioDefense Operations Lansing Inc. Mr. El-Hibri served as chairman of <a class="zem_slink" title="Digicel" rel="homepage" href="http://www.digicelgroup.com">Digicel</a> Holdings, Ltd., a <a class="zem_slink" title="Privately-held company" rel="wikipedia" href="http://en.wikipedia.org/wiki/Privately-held_company">privately held</a> telecommunications firm, from August 2000 to October 2006. He served as president of Digicel from August 2000 to February 2005. Mr. El-Hibri has served as chairman of East West Resources Corporation, a <a class="zem_slink" title="Venture capital" rel="wikipedia" href="http://en.wikipedia.org/wiki/Venture_capital">venture capital</a> and financial consulting firm, since June 1990. He served as president of East West Resources from September 1990 to January 2004. Mr. El-Hibri is a member of the board of trustees of American University and a member of the board of directors of the International <a class="zem_slink" title="Biomedical research" rel="wikipedia" href="http://en.wikipedia.org/wiki/Biomedical_research">Biomedical Research</a> Alliance, an academic joint venture among the NIH, <a class="zem_slink" title="University of Oxford" rel="geolocation" href="http://maps.google.com/maps?ll=51.7611,-1.2534&amp;spn=1.0,1.0&amp;q=51.7611,-1.2534%20%28University%20of%20Oxford%29&amp;t=h">Oxford University</a> and Cambridge University. He also serves as chairman and treasurer of El-Hibri Charitable Foundation. Mr. El-Hibri received a master&#8217;s degree in public and private management from Yale University and a B.A. in economics from Stanford University.</span></p>
<div class="zemanta-pixie" style="margin-top: 10px; height: 15px; text-align: justify;"><a class="zemanta-pixie-a" title="Reblog this post [with Zemanta]" href="http://reblog.zemanta.com/zemified/165db3a3-1c90-4c5d-a2c1-b95148c64df4/"><img class="zemanta-pixie-img" style="border: medium none; float: right;" src="http://img.zemanta.com/reblog_e.png?x-id=165db3a3-1c90-4c5d-a2c1-b95148c64df4" alt="Reblog this post [with Zemanta]" /></a><span class="zem-script more-related pretty-attribution"><script src="http://static.zemanta.com/readside/loader.js" type="text/javascript"></script></span></div>
]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.net/2009/07/06/mr-fuad-el-hibri-chief-executive-officer-and-chairman-emergent-biosolutions-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fuad El-Hibri Chief Executive Officer and Chairman of the Board of Directors</title>
		<link>http://fuad-elhibri.net/2009/07/06/fuad-el-hibri-chief-executive-officer-and-chairman-of-the-board-of-directors/</link>
		<comments>http://fuad-elhibri.net/2009/07/06/fuad-el-hibri-chief-executive-officer-and-chairman-of-the-board-of-directors/#comments</comments>
		<pubDate>Mon, 06 Jul 2009 00:31:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioPort Corporation]]></category>
		<category><![CDATA[Chairman of the Board]]></category>
		<category><![CDATA[Chairman of the Board of Directors]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Emergent]]></category>
		<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Fuad El-Hibri]]></category>
		<category><![CDATA[Board of directors]]></category>
		<category><![CDATA[Corporation]]></category>
		<category><![CDATA[Stanford University]]></category>
		<category><![CDATA[Subsidiary]]></category>
		<category><![CDATA[University of Oxford]]></category>
		<category><![CDATA[Venture capital]]></category>
		<category><![CDATA[Yale University]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.net/?p=4</guid>
		<description><![CDATA[Mr. Fuad El-Hibri has served as chief executive officer and chairman of the board of directors since June 2004 and as president from March 2006 to April 2007. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of BioPort Corporation from May 1998 until June 2004, when, as a result [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><span class="ccbnTxt">Mr. <a href="http://investors.emergentbiosolutions.com/phoenix.zhtml?c=202582&amp;p=irol-govBio&amp;ID=158319">Fuad El-Hibri</a> has served as <a class="zem_slink" title="Chief executive officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_executive_officer">chief executive officer</a> and chairman of the <a class="zem_slink" title="Board of directors" rel="wikipedia" href="http://en.wikipedia.org/wiki/Board_of_directors">board of directors</a> since June 2004 and as president from March 2006 to April 2007. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of <a class="zem_slink" title="NYSE: EBS" rel="stockexchange" href="http://finance.yahoo.com/q?s=EBS">BioPort</a> Corporation from May 1998 until June 2004, when, as a result of our <a class="zem_slink" title="Corporation" rel="wikipedia" href="http://en.wikipedia.org/wiki/Corporation">corporate</a> reorganization, BioPort became a <a class="zem_slink" title="Subsidiary" rel="wikipedia" href="http://en.wikipedia.org/wiki/Subsidiary">wholly owned subsidiary</a> of Emergent. We subsequently renamed BioPort as Emergent BioDefense Operations Lansing Inc. Mr. El-Hibri served as chairman of <a class="zem_slink" title="Digicel" rel="homepage" href="http://www.digicelgroup.com">Digicel</a> Holdings, Ltd., a <a class="zem_slink" title="Privately-held company" rel="wikipedia" href="http://en.wikipedia.org/wiki/Privately-held_company">privately held</a> telecommunications firm, from August 2000 to October 2006. He served as president of Digicel from August 2000 to February 2005. Mr. El-Hibri has served as chairman of East West Resources Corporation, a <a class="zem_slink" title="Venture capital" rel="wikipedia" href="http://en.wikipedia.org/wiki/Venture_capital">venture capital</a> and financial consulting firm, since June 1990. He served as president of East West Resources from September 1990 to January 2004. Mr. El-Hibri is a member of the board of trustees of American University and a member of the board of directors of the International <a class="zem_slink" title="Biomedical research" rel="wikipedia" href="http://en.wikipedia.org/wiki/Biomedical_research">Biomedical Research</a> Alliance, an academic joint venture among the NIH, <a class="zem_slink" title="University of Oxford" rel="geolocation" href="http://maps.google.com/maps?ll=51.7611,-1.2534&amp;spn=1.0,1.0&amp;q=51.7611,-1.2534%20%28University%20of%20Oxford%29&amp;t=h">Oxford University</a> and Cambridge University. He also serves as chairman and treasurer of El-Hibri Charitable Foundation. Mr. El-Hibri received a master&#8217;s degree in public and private management from Yale University and a B.A. in economics from Stanford University.</span></p>
<div class="zemanta-pixie" style="margin-top: 10px; height: 15px; text-align: justify;"><a class="zemanta-pixie-a" title="Reblog this post [with Zemanta]" href="http://reblog.zemanta.com/zemified/e323c2cf-8f30-46d8-a116-c9ef3ec11230/"><img class="zemanta-pixie-img" style="border: medium none; float: right;" src="http://img.zemanta.com/reblog_e.png?x-id=e323c2cf-8f30-46d8-a116-c9ef3ec11230" alt="Reblog this post [with Zemanta]" /></a><span class="zem-script more-related pretty-attribution"><script src="http://static.zemanta.com/readside/loader.js" type="text/javascript"></script></span></div>
]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.net/2009/07/06/fuad-el-hibri-chief-executive-officer-and-chairman-of-the-board-of-directors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
